Abstract #3050

Pancreatic Cancer Screening & Surveillance with MRI 7 Year Experience

Masoom A. Haider¹, Wigdan Al-Sukhni², Kartik S. Jhaveri¹, Heidi Rothenmund², Spring Holter², Steven Narod³, Malcolm Moore⁴, Stephanie Wilson⁵, Steven Gallinger²

¹Medical Imaging, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; ²Department of Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada; ³Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada; ⁴Department of Medicine, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; ⁵Medical Imaging, University Health Network, University of Toronto, Toronto, Ontario, Canada

High risk patients were screened annually with non-contrast 20 minute MRI protocol from 2003-2010. Pancreatic cancer was found in 2 of the 259 patients (0.7%): 57 yo female with a 1.5cm adenocarcinoma and a concomitant IPMN, stage IIB ; 80 yo male with unresectable pancreatic adenocarcinoma. IPMNs were seen in 14 patients (5.4%).Seven significant incidental findings (2.7%) were detected by MRI. MRI has the potential to detect pancreatic cancer in a high risk screening populations but frequent scanning and IV contrast and may be required to impact survival. IPMNs are a common finding.